Clinical Trial Update: A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 clinical trial of taspoglutide in patients with inadequately controlled Diabetes Mellitus Type 2 and cardiovascula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Taspoglutide (taspoglutide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 3 | Status: COMPLETED